Search

Your search keyword '"Granger C"' showing total 1,447 results

Search Constraints

Start Over You searched for: Author "Granger C" Remove constraint Author: "Granger C"
1,447 results on '"Granger C"'

Search Results

1. Facial Seborrheic Dermatitis in HIV-Seropositive Patients: Evaluation of the Efficacy and Safety of a Non-Steroidal Cream Containing Piroctone Olamine, Biosaccharide Gum-2 and Stearyl Glycyrrhetinate – A Case Series

2. A Treatment Combination of Peels, Oral Antioxidants, and Topical Therapy for Refractory Melasma: A Report of 4 Cases

3. A novel water-based anti-aging suncare formulation provides multifaceted protection and repair against environmental aggressors: evidence from in vitro, ex vivo, and clinical studies

4. Outdoor testing of the photoprotection provided by a new water-based broad-spectrum SPF50+ sunscreen product: two double-blind, split-face, randomized controlled studies in healthy adults

5. Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis

6. Protective effects of a novel facial cream against environmental pollution: in vivo and in vitro assessment

7. Antiaging effects of a novel facial serum containing L-ascorbic acid, proteoglycans, and proteoglycan-stimulating tripeptide: ex vivo skin explant studies and in vivo clinical studies in women

8. Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study

9. Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance

10. Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis

12. Characteristics, risk factors and outcomes of patients managed for left-sided infective endocarditis: A prospective study in a high-volume center

13. Exercise-induced pulmonary congestion is a promising marker to diagnose early stage heart failure in patients referred to rule out myocardial ischemia

15. Exercise-induced pulmonary congestion is a promising marker to diagnose early stage heart failure in patients referred to rule out myocardial ischemia

17. Characteristics, risk factors and outcomes of patients managed for left-sided infective endocarditis: a prospective study in a high-volume center

23. Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial

30. Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial

31. Atrial fibrillation in patients with high-risk acute myocardial infarction – the PARADISE-MI trial

32. Sacubitril/valsartan compared to ramipril in high risk post myocardial infarction patients stratified according use of mineralocorticoid receptor antagonists: insight from PARADISE MI trial

33. PARADISE-MI – event rates and treatment effect of sacubitril/valsartan v ramipril by the presence or absence of transient pulmonary congestion and/or LVEF less or greater than 40

34. Oral Presentation No. 53 Dose-related preprocedural patency of the infarct-related artery after zalunfiban (RUC-4) administration upon arrival at the catheterization laboratory in ST-elevation myocardial infarction: insights from the phase IIa study

35. Incidence and risk factors for major bleeding events in atrial fibrillation patients on direct oral anticoagulant therapy: data from the National Patient-Centered Clinical Research Network

37. Angiotensin receptor–neprilysin inhibition in acute myocardial infarction

39. ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016

47. Efficacy and Acceptability of a New Water-Soluble Nail Strengthener Containing Pistacia lentiscus and Hyaluronic Acid to Improve the Appearance of Brittle Nails versus Untreated Nails: In vitro and Clinical Evidence

49. Causal Inference

50. ESICM LIVES 2016: part one: Milan, Italy. 1-5 October 2016

Catalog

Books, media, physical & digital resources